Patient-Reported Outcomes Among Adults With Congenital Heart Disease in the Congenital Heart Initiative Registry.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 Oct 2024
Historique:
medline: 16 10 2024
pubmed: 16 10 2024
entrez: 16 10 2024
Statut: epublish

Résumé

In the US, there are more than 1.5 million adults living with congenital heart disease (CHD). The Congenital Heart Initiative (CHI) is a digital, online, patient-empowered registry that was created to advance multicenter research and improve clinical care by gathering patient-reported outcomes (PROs) in adults with CHD. To report the initial findings of the PROs for adults with CHD from the first 3 years of the CHI. The CHI was launched nationally on December 7, 2020, as an observational cohort (survey) study. Data were collected virtually through December 31, 2023, and stored on Health Insurance Portability and Accountability Act-compliant cloud-based servers with restricted access. Adults with CHD were recruited through email, social media, general advertising through advocacy organizations, and targeted outreach (telephone and in-clinic recruitment) by clinical centers. Demographics and validated survey tools on quality of life, mental health, physical activity, and health care utilization were collected at baseline and every 4 months. Descriptive statistics were used to understand the associations between various factors, including the complexity of heart defects, physical activity levels, mental health comorbidities, and socioeconomic and health care access variables. All categorical variables were analyzed using χ2 or Fischer exact test as appropriate. By December 31, 2023, the CHI had enrolled 4558 participants (2530 female [56%]) with a mean (SD) age of 38.5 (13.9) years, representing all 50 states. Approximately 88% of participants (3998 participants) completed at least 1 electronic visit as of December 31, 2023. The most prevalent CHD anatomy included tetralogy of Fallot (883 participants [22%]), transposition of great arteries (452 participants [11%]), and coarctation of the aorta (429 participants [11%]). Approximately 88% of participants (3998 participants) reported at least 1 comorbidity, with arrhythmia (1300 participants [33%]) as the most common cardiac comorbidity and mood disorder (1326 participants [35%]) as the most common noncardiac comorbidity. Among female participants, 45% (1147 participants) reported having had a pregnancy, with 38% (967 participants) resulting in biological children. Participants with complex CHD were less likely than those with moderate CHD to meet recommended physical activity guidelines (χ22 = 15.9; n = 3320; P < .001), a factor that was more pronounced among female participants. Overall health-related quality of life was rated as good or better by 84% of participants who completed the quality of life PROs (2882 participants), with no difference by CHD complexity. In this cohort study of adults living with CHD, many patients reported mood disorders, but most reported good health-related quality of life. The CHI, the largest registry of adults with CHD, is poised to facilitate multicenter research with the goal of improving clinical outcomes for all adults with CHD.

Identifiants

pubmed: 39412804
pii: 2824913
doi: 10.1001/jamanetworkopen.2024.39629
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2439629

Auteurs

Scott Leezer (S)

CURA Strategies, Arlington, Virginia.

Rittal Mehta (R)

Division of Pediatric Cardiology, Children's National Hospital, Washington, DC.

Anushree Agarwal (A)

Division of Cardiology, University of California San Francisco, San Francisco.

Sneha Saraf (S)

Division of Pediatric Cardiology, Children's National Hospital, Washington, DC.

Mindi Messmer (M)

Division of Pediatric Cardiology, Children's National Hospital, Washington, DC.

Ruth Phillippi (R)

Division of Pediatric Cardiology, Children's National Hospital, Washington, DC.

Jamie L Jackson (JL)

Center for Behavioral Health, Nationwide Children's Hospital, Columbus, Ohio.

Mark Roeder (M)

Adult Congenital Heart Association, Philadelphia, Pennsylvania.

Aliza Marlin (A)

Adult Congenital Heart Association, Philadelphia, Pennsylvania.

Noah D Peyser (ND)

Division of Cardiology, University of California San Francisco, San Francisco.

Mark J Pletcher (MJ)

Division of Cardiology, University of California San Francisco, San Francisco.

Richard Krasuski (R)

Division of Cardiology, Duke University Health System, Durham, North Carolina.

Matthew Lewis (M)

Division of Cardiology, Columbia University Irving Medical Center, New York, New York.

Leigh Reardon (L)

Division of Pediatric Cardiology, University of California Los Angeles, Los Angeles.

Arwa Saidi (A)

Congenital Heart Center, University of Florida, Gainesville.

Ronald Kanter (R)

Division of Pediatric Cardiology, Nicklaus Children's Hospital, Miami, Florida.

Satinder Sandhu (S)

Division of Pediatric Cardiology, University of Miami, Miami, Florida.

Thomas Young (T)

Division of Pediatric Cardiology, Ochsner Health, New Orleans, Louisiana.

Roni Jacobsen (R)

Division of Pediatric Cardiology, Children's Hospital of Colorado, Denver.

Emily Ruckdeschel (E)

Division of Pediatric Cardiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Adam Lubert (A)

Division of Pediatric Cardiology, Cincinnati Children's Hospital, Cincinnati, Ohio.

Simran Singh (S)

Division of Cardiology, Weill Cornell Medicine, New York, New York.

Ali Zaidi (A)

Division of Cardiology, Mt. Sinai Hospital, New York, New York.

Dan H Halpern (DH)

Division of Cardiology, NYU Langone Health, New York, New York.

Anita Mathews (A)

Division of Pediatric Cardiology, Children's National Hospital, Washington, DC.

Thomas Carton (T)

Louisiana Public Health Institute, New Orleans.

Anitha S John (AS)

Division of Pediatric Cardiology, Children's National Hospital, Washington, DC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH